Alcyomics®

Alcyomics® is a unique pre-clinical service provider of Skimune®, human skin explants for safety and efficacy assessment of novel compounds and drugs

[Alcyomics® @Alcyomics]

If you are interested in finding out more about our Skimune® platform assays, please visit our website, https://t.co/nPVV59m4mZ

[Alcyomics® @Alcyomics]

Our assay is capable of a wide array of readouts.

Saves time and money in product development.

Can distinguish the type of hypersensitivity reaction.

Readouts include cytokine release, immunohistochemistry and histopathology.
Contact us for more info
[email protected]

[Alcyomics® @Alcyomics]

@NC3Rs @BBSRC Sounds good. Alcyomic will be checking it out!

[Society of Toxicology @SOToxicology]

#SOTTV presents “Alcyomics Ltd.” Gain insight on the work being done at @Alcyomics and how its approach to using a human-based system may help predict adverse immune reactions to compounds in this paid film by @WebsEdge_Med. https://t.co/ILrT3u0ENx

[Northern Alliance ATTC @naattc]

Hear from Professor Anne Dickinson, Founder and CEO of @Alcyomics, who explains how their products can help support the safety profile in Cell and Gene Therapy products.
Watch ➡️ https://t.co/MTWEEPlUXx

[Alcyomics® @Alcyomics]

@naattc @AnneBlackPharm @neilwwatson66 @cvniekerk1 @CGTCatapult @givebloodscot @LeedsHospitals Great to be part if NAATC!

[Northern Alliance ATTC @naattc]

🧬Here are many of the Northern Alliance team who met this week to celebrate the success of the project so far and plan for the future...🧬

[Dan Carr @daniel_f_carr]

Our recent paper in JITC describing a really fascinating case of #SJS secondary to contrast media following #ICI the therapy. Biological samples from this patient are already helping us to understand the mechanism of pathogenesis in skin blistering ADRs. https://t.co/dIjw6H2G0c

[The Biosphere @BiosphereNCL]

On @ScienceWeekUK we want say how proud we are of all of the businesses and scientists that call @BiosphereNCL home - Innovating for the future and supporting people to live well. #BSW21

[Sadaf Ashraf @SadafAshraf15]

@nvisionabdn Loved the realistic comparison of career progression within academia versus industry. Thanks Claire Pearce @EvOx_Ltd and Shaheda Ahmed @Alcyomics.

[The Biosphere @BiosphereNCL]

For International Women's Day & British Science Week 2020 we celebrated the careers of several influential women working in STEM, including @ChiOnwurah MP, Professor Ruth Plummer (@UniofNewcastle) & Dr Shaheda Ahmed (@Alcyomics)
https://t.co/oy4H6sGnM1 #WomenInSTEM

[Alcyomics® @Alcyomics]

Discovered this event - Festival of Biologics USA on #FOBUSA2021 We will be there! https://t.co/UBXWueeie5 #FOBUSA2021 via @totalbiopharma

[Dan Carr @daniel_f_carr]

Theres still time to apply for this exciting PhD studentship working in my group in collaboration with @ImmunoPharm and @Alcyomics developing models of severe skin adverse drug reactions. happy to chat with anyone interested
([email protected]). https://t.co/yZQjXlm1LA

[DiMeN DTP @DiMeN_DTP]

Planning on applying for a PhD to start in 2021?

@The_MRC funded project with DiMeN:
Use of 3D skin models to elucidate the molecular pathogenesis of epidermal detachment in severe drug-induced skin reactions

Liverpool: Dr Dan Carr & iCASE @Alcyomics

https://t.co/Ueh4UnoMl5

[Dan Carr @daniel_f_carr]

Exciting @DiMeN_DTP funded PhD opportunity in my group working with ⁦@ImmunoPharm⁩ at ⁦⁦@LivUniISMIB ⁦@LivUni⁩ and ⁦@Alcyomics⁩ developing in vitro models of severe skin adverse drug reactions. https://t.co/yZQjXlm1LA

[Northern Alliance ATTC @naattc]

We’re delighted that our partner @Alcyomics has been successful in its bid for a Fast Start grant of £50,000 from @innovateuk to undertake critical scientific support to aid in the development of a vaccine for #COVID19. Read more ⬇️

https://t.co/FPR97FnYYu

[Alcyomics® @Alcyomics]

Check out this @REPROCELLglobal webinar. Alcyomics will be presenting our #immune based assays for #covid19 drug discovery.

[REPROCELL @_REPROCELL]

Interested in COVID research? Check out our upcoming webinar about Assays and Resources for COVID-19 Research at https://t.co/Qt4hgtPuLc

[Alcyomics® @Alcyomics]

Regulatory #safety guidelines for novel product classes can be insufficient. Here authors present a case for developing a new regulatory approach for the safety assessment of a specific category of biological medicinal products. https://t.co/dp854tK4Pq

[Alcyomics® @Alcyomics]

IIVS' outreach program for non-animal test methods supported by Chinese #cosmetic company. Good news showing this important market moving towards #nonaninal based tests. https://t.co/11ILW1KeVP via @the_iivs @EurekAlert

[Alcyomics® @Alcyomics]

Join us for our webinar today - discussing strategies to assess #immunogencity and #immunotoxicity to #smallmolecules and #biologics using human-based platforms.

Tuesday 23rd July. Register here:
12pm (BST) - https://t.co/uaBX6GdUeZ
5pm (BST) - https://t.co/lFyIG7Lj2t

[Alcyomics® @Alcyomics]

Join us for our next webinar 'Providing Safety Testing Solutions for the Pharmaceutical Industry' on Tuesday 23rd June. #smallmolecule, #biologics #drugdiscovery #Skimune

Register here:
12pm (BST) - https://t.co/uaBX6GdUeZ
5pm (BST) - https://t.co/lFyIG7Lj2t